Recent advances in the search for new anti-coccidial drugs (Q34593987)

3 August 2017

1 reference

title

Recent advances in the search for new anti-coccidial drugs (English)

1 reference

3 August 2017

Coombs GH

1

1 reference

PubMed ID

11943222

3 August 2017

Müller S

series ordinal

2

1 reference

3 August 2017

1 May 2002

1 reference

International Journal for Parasitology

3 August 2017

1 reference

3 August 2017

32

1 reference

3 August 2017

5

1 reference

3 August 2017

497-508

1 reference

Cell: sporozoite interactions and invasion by apicomplexan parasites of the genus Eimeria

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

The biochemical basis of arsenical-diamidine crossresistance in African trypanosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Recent advances in identifying and validating drug targets in trypanosomes and leishmanias.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Thioredoxin reductase as a pathophysiological factor and drug target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Inhibition of cytoplasmic and organellar protein synthesis in Toxoplasma gondii. Implications for the target of macrolide antibiotics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Characterization of iron-dependent endogenous superoxide dismutase of Plasmodium falciparum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

New agents to combat malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Identification of Cryptosporidium parvum dihydrofolate reductase inhibitors by complementation in Saccharomyces cerevisiae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Treatment with beta-cyclodextrin of natural Cryptosporidium parvum infections in lambs under field conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Protein prenyl transferase activities of Plasmodium falciparum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Serine protease inhibitors block invasion of host cells by Toxoplasma gondii.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Active isoprenoid pathway in the intra-erythrocytic stages of Plasmodium falciparum: presence of dolichols of 11 and 12 isoprene units

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Comparison of the phosphofructokinase and pyruvate kinase activities of Cryptosporidium parvum, Eimeria tenella and Toxoplasma gondii

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Origins of hydrogenosomes and mitochondria: evolution and organelle biogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

The protozoan parasite Toxoplasma gondii expresses two functional plant-like glycolytic enzymes. Implications for evolutionary origin of apicomplexans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Anti-oxidant enzymes in Cryptosporidium parvum oocysts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Molecular cloning and characterization of a putative glutathione reductase gene, the PfGR2 gene, from Plasmodium falciparum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Activity of benzimidazoles against cryptosporidiosis in neonatal BALB/c mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

A plastid organelle as a drug target in apicomplexan parasites.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

In vitro assays elucidate peculiar kinetics of clindamycin action against Toxoplasma gondii

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Subcellular localization and characterization of chorismate synthase in the apicomplexan Plasmodium falciparum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Metronidazole. A therapeutic review and update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Efficacy of nitazoxanide, tizoxanide and tizoxanide glucuronide against Cryptosporidium parvum development in sporozoite-infected HCT-8 enterocytic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Management of toxoplasmosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

The plastid in Apicomplexa: what use is it?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Chemotherapy of human and animal coccidioses: state and perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Drug uptake via nutrient transporters in Trypanosoma brucei.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Mechanism of triclosan inhibition of bacterial fatty acid synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Identification and characterisation of Toxoplasma gondii protein farnesyltransferase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Differential localisation of an Eimeria tenella aspartyl proteinase during the infection process.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Targeting and subcellular localization of Toxoplasma gondii catalase. Identification of peroxisomes in an apicomplexan parasite.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Antiprotozoal activities of benzimidazoles and correlations with beta-tubulin sequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Evaluation of in vitro activity of aurones and related compounds against Cryptosporidium parvum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Shikimate pathway in apicomplexan parasites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Polyamine biosynthesis in Cryptosporidium parvum and its implications for chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

A plastid of probable green algal origin in Apicomplexan parasites.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

The malaria parasite Plasmodium falciparum possesses a functional thioredoxin system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Isolation and functional analysis of two thioredoxin peroxidases (peroxiredoxins) from Plasmodium falciparum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Plasmodium falciparum-infected red blood cells depend on a functional glutathione de novo synthesis attributable to an enhanced loss of glutathione

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

The apicoplast: a new member of the plastid family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Bisphosphonates inhibit the growth of Trypanosoma brucei, Trypanosoma cruzi, Leishmania donovani, Toxoplasma gondii, and Plasmodium falciparum: a potential route to chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Characterization of cytochrome b from Toxoplasma gondii and Q(o) domain mutations as a mechanism of atovaquone-resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Plastid in human parasites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Apicomplexan plastids as drug targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Development of cysteine protease inhibitors as chemotherapy for parasitic diseases: insights on safety, target validation, and mechanism of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Triclosan inhibits the growth of Plasmodium falciparum and Toxoplasma gondii by inhibition of apicomplexan Fab I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

In vitro and in vivo activities of nitazoxanide against Clostridium difficile

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Superoxide dismutases in Eimeria tenella

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Recombinant putative glutathione reductase of Plasmodium falciparum exhibits thioredoxin reductase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

In the human malaria parasite Plasmodium falciparum, polyamines are synthesized by a bifunctional ornithine decarboxylase, S-adenosylmethionine decarboxylase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Targeting polyamines of parasitic protozoa in chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Molecular cloning, expression analysis and iron metal cofactor characterisation of a superoxide dismutase from Toxoplasma gondii

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Parasite cyclophilins and antiparasite activity of cyclosporin A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Some phosphonic acid analogs as inhibitors of pyrophosphate-dependent phosphofructokinase, a novel target in Toxoplasma gondii

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Toxoplasma gondii: in vivo and in vitro studies of a mutant resistant to arprinocid-N-oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Antimalarial activity of new gossypol derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Methionine recycling as a target for antiprotozoal drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Shikimate pathway in apicomplexan parasites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Optical and radiocarbon dating at Jinmium rock shelter in northern Australia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Vacuolar proton pyrophosphatase activity and pyrophosphate (PPi) in Toxoplasma gondii as possible chemotherapeutic targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Therapy with atovaquone for Cryptosporidium parvum infection in neonatal severe combined immunodeficiency mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Pyruvate : NADP+ oxidoreductase from the mitochondrion of Euglena gracilis and from the apicomplexan Cryptosporidium parvum: a biochemical relic linking pyruvate metabolism in mitochondriate and amitochondriate protists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Oxidative stress as a defense mechanism against parasitic infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

The mannitol cycle--a new metabolic pathway in the Coccidia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Evidence for and characterization of a mannitol cycle in Eimeria tenella

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Crystal structures of Toxoplasma gondii HGXPRTase reveal the catalytic role of a long flexible loop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Crystal structures of Toxoplasma gondii uracil phosphoribosyltransferase reveal the atomic basis of pyrimidine discrimination and prodrug binding.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Crystal structures of Toxoplasma gondii adenosine kinase reveal a novel catalytic mechanism and prodrug binding 1 1Edited by I. A. Wilson

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Cysteine protease inhibitors as chemotherapy: lessons from a parasite target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Superoxide dismutase and catalase in Toxoplasma gondii.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Comparison of efficacies of cysteine protease inhibitors against five strains of Plasmodium falciparum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Methionine recycling pathways and antimalarial drug design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Ultrastructural analysis of the sporozoite of Cryptosporidium parvum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

The mitosome, a novel organelle related to mitochondria in the amitochondrial parasite Entamoeba histolytica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Dinitroaniline herbicides against protozoan parasites: the case of Trypanosoma cruzi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Respiration and oxidative phosphorylation in the apicomplexan parasite Toxoplasma gondii

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Glycolysis as a target for the design of new anti-trypanosome drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Isoprenoid biosynthesis and drug targeting in the Apicomplexa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Apicomplexan parasites possess distinct nuclear-encoded, but apicoplast-localized, plant-type ferredoxin-NADP+ reductase and ferredoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Protein trafficking to the plastid of Plasmodium falciparum is via the secretory pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Mode of anticoccidal action of arprinocid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

[(1)N,(12)N]Bis(Ethyl)-cis-6,7-dehydrospermine: a new drug for treatment and prevention of Cryptosporidium parvum infection of mice deficient in T-cell receptor alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Thioredoxin reductase two modes of catalysis have evolved

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

The Plasmodium falciparum bifunctional ornithine decarboxylase, S-adenosyl-L-methionine decarboxylase, enables a well balanced polyamine synthesis without domain-domain interaction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Cryptosporidium parvum appears to lack a plastid genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Molecular analysis of a Type I fatty acid synthase in Cryptosporidium parvum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Growth of Toxoplasma gondii is inhibited by aryloxyphenoxypropionate herbicides targeting acetyl-CoA carboxylase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

Biochemistry of the coccidia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Targeting the shikimate pathway in the malaria parasite Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900354-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0020-7519(01)00354-X

1 reference

3 August 2017

1 reference

PubMed ID

11943222